维普中文期刊产品整合服务
20篇 您的检索式:作者名="Boddy AV"
    题名 作者 年代 出处 被引量
1Individual variation in the ac tivation and inactivation of metabolic pathways of cyclophosphamide显示文摘Boddy AV Furtun Y Sardas S 1992J Natl Cancer Inst1992,84,:1
2A clinical and pharmacokinetie study of the combination of carbop latin and paclitaxel for epithelial ovarian caner显示文摘Siddiqui N Boddy AV Thomas HD 0,,02:1
3A clinical and pharmacokinetic study of the combination of earboplatin and paelitaxel for epithelial ovarian cancer显示文摘Siddiqui N Boddy AV Thomas HP 1997Br J Cancer1997,75,2:1
4Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors显示文摘Raft I Boddy AV Calvete JA 1998J Clin Oncol1998,16,3:1
5Pharmacogenetics of genes across the doxorubicin pathway显示文摘Jamieson D Boddy AV 2011Expert Opin Drug Metab Toxico12011,7,10:1
6A clinical and pharmacokinctic study of the combination of carboplatin and paclitaxel for epithelial ovarian caner 显示文摘Siddiqui N Boddy AV Thomas HD 1997British Journal of Cancer1997,75,2:1
7A clinical and pharmacokinetie Study of the combination of carboplatin and paclitaxel for epithelial ovarian caner显示文摘Siddiqui N Boddy AV Thomas HD 1997Br Cancer1997,75,2:1
8A clinical and pharmacokinetie study of the combination of carboplatin and paclitaxel for epithelial ovarian caner显示文摘Siddiqui N Boddy AV Thomas HD 1997Br J Cancer1997,75,2:1
9A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancer显示文摘Siddiqui N Boddy AV Thomas HD 1997Br J Cancer1997,75,2:1
10Metablisom and pharmacokinetics of oxaza phosphorines显示文摘Boddy AV Yule SM 2000Drug Dispos Clin Pharmacokinet2000,38,4:1
11A phase I and pharmaco- kinetic study of paclitaxel poliglumex ( XYOTAX ) , investigating both 3-weekly and 2-weekly schedules 显示文摘Boddy AV Plummer ER Todd R 2005Clin Cancer Res2005,11,21:1
12Cyclophosphamide metabolism in children显示文摘Yule SM Boddy AV Cole M 1995Cancer Res1995,55,4:1
13A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancer显示文摘Siddiqui N Boddy AV Thomas HD 1997Br J Cancer1997,75,2:1
14A clinical and phamaco - ki-netic study of the carboplation and paclitqaxel for epidieli-al ovariancer显示文摘Siddiqui N Boddy AV Thom as HD 1997Br J Cancer1997,75,:1
15A clinical and pharma-cokinetic study of the combination of carboplatin and paclitaxel for ep-ithelial ovarian caner显示文摘Siddiqui N Boddy AV Thomas HD 1997British Journal of Cancer1997,75,2:1
16Aclinical andpharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancer显示文摘Siddiqui N Boddy AV Thomas HD 1997BrJ Cancer1997,75,2:1
17A clinical and phamacokinetie study of the combination of carboplatin and paclitaxel for epithelial ovarian cancer显示文摘Siddiqui N Boddy AV Thamas HD 1997Br J Cancer1997,75,2:1
18A clinical and phamacoki - netie study of the earboplation and paclitaxel for epidieli - al ovariancer显示文摘Siddiqui N Boddy AV Thorn as HD 1997BrJ Cancer1997,75,:1
19Pharmacogenetics of genes across the doxorubicin pathway显示文摘Jamieson D Boddy AV 2011Expert Opin Drug Metab Toxicol2011,7,10:1
20Preclincal and phase Ⅰ clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors显示文摘Rafi I Boddy AV Calvete JA 1998J Clin Oncol1998,16,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费